Results 261 to 270 of about 371,981 (337)
Preserved bevacizumab (Avastin®) eye drops for application in multidose containers - an in-vitro characterisation. [PDF]
Lessiak U +8 more
europepmc +1 more source
Clinical utility of voriconazole eye drops in ophthalmic fungal keratitis
David C. M. Kong +3 more
openalex +2 more sources
A new, solution‐processable class of optical materials based on molecular hybrids of metal oxide hydrates and commodity polymers is discussed here, including their synthesis, processing into thin films, patterning, and photonic structures realized to date.
Victoria Quirós‐Cordero +9 more
wiley +1 more source
Pharmacological Treatment of Presbyopia Using Pilocarpine 1.25% Eye Drops. [PDF]
Mousavi SA +8 more
europepmc +1 more source
Reversible adhesion via host–guest complex formation at the polymer interface is achieved by externally controlling the complexation through applied stimuli. Neutron reflectometry analysis of the adhesion interface revealed that the presence of host–guest complexes hinders the polymer interdiffusion by despite promoting adhesion strength.
Kenji Yamaoka +11 more
wiley +1 more source
Efficacy of 3% diquafosol sodium eye drops at different frequencies in the treatment of dry eye after FS-LASIK. [PDF]
Wang JJ +7 more
europepmc +1 more source
Effect of five years of treatment with nipradilol eye drops in patients with normal tension glaucoma
Kenji Inoue +3 more
openalex +2 more sources
Probiotic‐Based Materials as Living Therapeutics
Recent advances in Engineered Living Materials are highlighted, integrating synthetic biology and advanced materials, with a focus on probiotic‐based therapeutics. Probiotic Living Materials hold great potential for biosensing, infection treatment, osteogenesis, wound healing, vaginal and gastrointestinal disorders, and cancer therapy. breakthroughs in
Laura Sabio +2 more
wiley +1 more source
Interpretation of expert consensus on the application of low-concentration atropine eye drops in the prevention and control of myopia in children and adolescents. [PDF]
Li L.
europepmc +1 more source

